LOVELAND, Colo., Feb. 9, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a providerof advanced veterinary diagnostic and specialty products, plans to announce its fourth quarter and year end 2017 financial results in a press release to be issued on Wednesday, February 28, 2018 before the market opens.
To access the conference call:
From within the United States, please dial 1-800-239-9838From outside of the United States, please dial 1-323-794-2551Reference Conference ID: 9385771
The conference call will be webcast live from the Company's website on www.heska.com.
A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Wednesday, March 7, 2018.
To access the replay:
From within the United States, please dial 1-844-512-2921From outside the United States, please dial 1-412-317-6671Reference Replay Pin Number: 9385771
The webcast will also be archived on www.heska.com for 90 days.
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
Contact Heska today at 800.464.3752 and visit www.heska.com for more information.
View original content:http://www.prnewswire.com/news-releases/heska-schedules-fourth-quarter-and-year-end-2017-financial-results-conference-call-for-february-28-2018-300596291.html
SOURCE Heska Corporation
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All